These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14970095)

  • 21. Randomized controlled trials with statistically nonsignificant results.
    Allison DB; Cope MB
    JAMA; 2010 Sep; 304(9):965; author reply 965. PubMed ID: 20810373
    [No Abstract]   [Full Text] [Related]  

  • 22. Addressing conflict in strategic literature reviews: disclosure is not enough.
    Michaels D
    J Epidemiol Community Health; 2009 Aug; 63(8):599-600. PubMed ID: 19596838
    [No Abstract]   [Full Text] [Related]  

  • 23. Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.
    Bridoux V; Moutel G; Schwarz L; Michot F; Herve C; Tuech JJ
    World J Surg; 2014 Oct; 38(10):2487-93. PubMed ID: 24824646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conflict of interest and AJOB.
    Carroll KA; McGee G
    Am J Bioeth; 2002; 2(3):1-2. PubMed ID: 12230839
    [No Abstract]   [Full Text] [Related]  

  • 25. Three journals raise doubts on validity of Canadian studies.
    White C
    BMJ; 2004 Jan; 328(7431):67. PubMed ID: 15132140
    [No Abstract]   [Full Text] [Related]  

  • 26. Disclosure of research funds.
    Axtens M
    Aust Fam Physician; 1998 Jul; 27 Suppl 2():S112. PubMed ID: 9679368
    [No Abstract]   [Full Text] [Related]  

  • 27. Sources of bias in the economic analysis of new drugs. Health Outcomes Committee Pharmaceutical Research and Manufacturers of America, Washington, DC.
    Gagnon JP
    JAMA; 2000 Mar; 283(11):1423; author reply 1424. PubMed ID: 10732925
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical issues and clinical trials.
    Shimm DS; Spece RG
    Drugs; 1993 Oct; 46(4):579-84. PubMed ID: 7506646
    [No Abstract]   [Full Text] [Related]  

  • 29. What is right and what is wrong about evidence-based medicine?
    Julian DG
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S2-5. PubMed ID: 12950509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The politics of disclosure.
    Tan LB
    Lancet; 1996 Nov; 348(9037):1314-5. PubMed ID: 8909402
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic beneficence and patient recruitment in randomized controlled clinical trials.
    Mann H
    Am J Bioeth; 2002; 2(2):35-6. PubMed ID: 12189074
    [No Abstract]   [Full Text] [Related]  

  • 32. [Selective reporting--greater problem than selective publishing?].
    Melander H
    Lakartidningen; 2005 Jan 24-30; 102(4):224-5. PubMed ID: 15743133
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical reviews face criticism over lapses.
    Armstrong D
    Wall St J (East Ed); 2006 Jul; ():B1, B2. PubMed ID: 16909499
    [No Abstract]   [Full Text] [Related]  

  • 34. RE: Secret ties to industry and conflicting interests in cancer research.
    Wakeford R
    Am J Ind Med; 2007 Mar; 50(3):239-40. PubMed ID: 17315183
    [No Abstract]   [Full Text] [Related]  

  • 35. Conflicts of interest. Research gone bad?
    Serb C
    Hosp Health Netw; 1998 Aug 5-20; 72(15-16):76. PubMed ID: 9738151
    [No Abstract]   [Full Text] [Related]  

  • 36. Medicine in the Noise Age: what can we believe?
    Angell M
    Account Res; 2001; 8(3):189-95. PubMed ID: 12481786
    [No Abstract]   [Full Text] [Related]  

  • 37. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 38. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
    Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
    Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supporting the need for rigorous enforceable disclosure policies for scientific journals.
    Sass J
    Addiction; 2009 Nov; 104(11):1788-9. PubMed ID: 19832781
    [No Abstract]   [Full Text] [Related]  

  • 40. Researchers' links with biomed industry lead to bias in clinical trials.
    Matthews R
    New Sci; 2003 Feb; 177(2380):8. PubMed ID: 14587489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.